Literature DB >> 23276939

TGM2 and implications for human disease: role of alternative splicing.

Thung-S Lai1, Charles S Greenberg.   

Abstract

Alternative splicing is an important mechanism for modulating gene function that accounts for a considerable proportion of proteomic complexity in higher eukaryotes. Alternative splicing is often tightly regulated in a cell-type- or developmental-stage- specific manner and can cause a single gene to have multiple functions. Human Tissue transglutaminase (TGM2) is a multifunctional enzyme with transglutaminase crosslinking (TGase), G protein signaling and kinase activities that are postulated to play a role in many disease states. TGM2 mRNA is regulated by alternative splicing, producing C-terminal truncated forms of TGM2 that are predicted to have distinct biochemical properties and biological functions. In this review, we will discuss how alternatively spliced forms of TGM2 could modulate its roles in cancer, neurodegeneration, inflammation and wound healing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23276939     DOI: 10.2741/4117

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  14 in total

1.  Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.

Authors:  Matthew D Dun; Robert J Chalkley; Sam Faulkner; Sheridan Keene; Kelly A Avery-Kiejda; Rodney J Scott; Lasse G Falkenby; Murray J Cairns; Martin R Larsen; Ralph A Bradshaw; Hubert Hondermarck
Journal:  Mol Cell Proteomics       Date:  2015-06-03       Impact factor: 5.911

2.  Secrets of the cutaneous basement membrane.

Authors:  Sarolta Karpati
Journal:  J Invest Dermatol       Date:  2014-03       Impact factor: 8.551

3.  The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability.

Authors:  Garima Singh; Jingwen Zhang; Yilun Ma; Richard A Cerione; Marc A Antonyak
Journal:  J Biol Chem       Date:  2016-02-18       Impact factor: 5.157

4.  Induction and translocation of tissue transglutaminase isoforms increased phosphorylation in retinoic acid treated erythroleukemia cells.

Authors:  Bassam M Fraij
Journal:  Protein J       Date:  2013-08       Impact factor: 2.371

5.  TGM2: a cell surface marker in esophageal adenocarcinomas.

Authors:  Deborah T Leicht; Tasneem Kausar; Zhuwen Wang; Daysha Ferrer-Torres; Thomas D Wang; Dafydd G Thomas; Jules Lin; Andrew C Chang; Lin Lin; David G Beer
Journal:  J Thorac Oncol       Date:  2014-06       Impact factor: 15.609

Review 6.  Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family.

Authors:  Benedict Onyekachi Odii; Peter Coussons
Journal:  ScientificWorldJournal       Date:  2014-03-23

7.  Identification of transglutaminase reactive residues in human osteopontin and their role in polymerization.

Authors:  Brian Christensen; Elias D Zachariae; Carsten Scavenius; Morten Thybo; Morten M Callesen; Søren Kløverpris; Claus Oxvig; Jan J Enghild; Esben S Sørensen
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

8.  Platelet-Released Growth Factors and Platelet-Rich Fibrin Induce Expression of Factors Involved in Extracellular Matrix Organization in Human Keratinocytes

Authors:  Andreas Bayer; Bernard Wijaya; Lena Möbus; Franziska Rademacher; Meno Rodewald; Mersedeh Tohidnezhad; Thomas Pufe; Daniel Drücke; Regine Gläser; Jürgen Harder
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

Review 9.  The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression.

Authors:  Claudio Tabolacci; Angelo De Martino; Carlo Mischiati; Giordana Feriotto; Simone Beninati
Journal:  Med Sci (Basel)       Date:  2019-01-25

Review 10.  Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.

Authors:  Tiina Rauhavirta; Minna Hietikko; Teea Salmi; Katri Lindfors
Journal:  Clin Rev Allergy Immunol       Date:  2019-08       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.